Publisher
Springer Berlin Heidelberg
Reference39 articles.
1. Albaramki J, Hodson EM, Craig JC, Webster AC (2012) Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev 2012 Jan 18; 1:CD00785–7
2. Auerbach M, Ballard H (2010): Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program: 338–347
3. Baker WF, Bick RL (1999) Treatment of hereditary and acquired thrombophilic disorders. Semin Thromb Hemost 25:387–406
4. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A (2009) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. The Lancet 373:1532–1542
5. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A et al (NORVIT Trial Investigators) (2006): Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354: 1578–1588